University of California, Berkeley, United States of America.
University of California Davis, United States of America.
Neuroimage Clin. 2019;23:101868. doi: 10.1016/j.nicl.2019.101868. Epub 2019 Jun 24.
Over the past six months, we have been in discussion with you and the authors of a recent publication in NeuroImage: Clinical (Amyloid pathology fingerprint differentiates posttraumatic stress disorder and traumatic brain injury. Mohamed AZ, et al. Neuroimaging Clinical 2018 Jun 5;19:716-726). We raised a variety of methodological concerns with Mohamed and colleagues and discussion about these concerns led to their preparation of a corrigendum to be published in NeuroImage: Clinical. We appreciate that the authors were responsive to our concerns and made a number of changes as noted in the corrigendum. Ultimately, however, the corrigendum does not address the primary conclusions of the study, which we were unable to replicate. We are troubled by the publication of results that cannot be replicated using identical methods and participant data. This is a letter to the authors to address these concerns.
在过去的六个月里,我们一直在与你以及最近在《NeuroImage: Clinical》上发表的一篇文章的作者进行讨论[1]。我们对 Mohamed AZ 等人提出了各种方法学上的担忧,并就这些担忧进行了讨论,最终导致他们准备发表一篇勘误表[2]。我们赞赏作者对我们的担忧做出了回应,并根据勘误表进行了一些修改。然而,最终勘误表并没有解决研究的主要结论,我们无法复制这些结论。我们对使用相同方法和参与者数据无法复制的结果的发表感到困扰。这是一封致作者的信,旨在解决这些担忧。
[1] Mohamed AZ, et al. Amyloid pathology fingerprint differentiates posttraumatic stress disorder and traumatic brain injury. NeuroImage: Clinical. 2018 Jun 5;19:716-726.
[2] Mohamed AZ, et al. Corrigendum to "Amyloid pathology fingerprint differentiates posttraumatic stress disorder and traumatic brain injury" [NeuroImage: Clinical 19 (2018) 716-726]. NeuroImage: Clinical. 2018 Nov 1;20:110010.